Detska Fakultna Nemocnica S Poliklinikou Banska Bystrica
- Address
- Namestie Ludvika Svobodu 4, 974 01 Banská Bystrica, Slovakia
Detska Fakultna Nemocnica S Poliklinikou Banska Bystrica - Pediatric Oncology and Infectious Disease Research Center
Detska Fakultna Nemocnica S Poliklinikou Banska Bystrica is a specialized pediatric research facility with distinguished expertise in hematologic malignancies and infectious diseases in children and adolescents. The center participates in major international collaborative treatment protocols, contributing to the advancement of pediatric oncology and antimicrobial therapy.
- Acute lymphoblastic leukemia (ALL) treatment protocols with advanced immunotherapy approaches including Blinatumomab and proteasome inhibitors
- Lymphoblastic lymphoma management with optimized CNS prophylaxis and risk-stratified treatment intensification
- Neonatal and infant sepsis research focusing on gram-negative bacterial infections and novel antimicrobial agents
The center's participation in AIEOP-BFM ALL 2017 and LBL 2018 protocols demonstrates its commitment to cutting-edge pediatric oncology research, incorporating precision medicine approaches based on genetic profiling and minimal residual disease monitoring. Additionally, their involvement in pharmacokinetic studies of Aztreonam-Avibactam for neonatal infections highlights expertise in vulnerable pediatric populations, addressing critical treatment gaps in hospital-acquired infections, ventilator-associated pneumonia, and bloodstream infections in the youngest patients.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 2 of 4 therapeutic areas and 15 of 30 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 3 by active trials.
- 1Pfizer Inc.1active
lock +2 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Pfizer Inc.2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 353 other sites in Slovakia
Therapeutic Area Benchmark — Slovakia
Select a therapeutic area to compare against other sites in Slovakia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Slovakia
Market Share
Country: Slovakia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Detska Fakultna Nemocnica S Poliklinikou Banska Bystrica
lock Showing 1 of 5 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Bortezomib, Blinatumomab, and Methotrexate in Pediatric Acute Lymphoblastic Leukemia: A Randomized Controlled Trial | Universitaetsklinikum Schleswig-Holstein AöR | Phase III | Not Recruiting | Jul 2018 | — |
IMP list
lock Showing 1 of 30 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Cyclophosphamide | 2 | Unknown | 2018-07-15 | 2019-08-01 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.